Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints Andrew Mackie as chief business officer

He is also inducted as executive director to the board

UK-based Ergomed has named Andrew Mackie as chief business officer and executive director to its board.

Mackie brings over 25 years of experience in pre clinical research, clinical and business development to the role and has held a number of senior R&D roles at Novartis and Sanofi. 

He joins from Lilly, where he was part of the business development team.

Miroslav Reljanovic, CEO at Ergomed, commented: “Over the past ten years, Andrew has worked with Ergomed as a consultant, and has been instrumental in developing the co-development business model, acting as lead negotiator on the partnerships signed to date. 

“His successful track record in drug development and deal making not only strengthens our capabilities as we continue to advance our co-development pipeline but ensures we have the right team in place as we look to expand through organic growth and acquisitions.”

After ten years in R&D, Mackie joined the UK biotech sector in 1997 at oncology specialist Antisoma, where he established the clinical development department and transitioned new molecules into development.

Ergomed provides specialised services to the pharma industry and the development of new drugs. 

6th July 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....

Infographics